
The global market for COVID-19 Kits was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for COVID-19 Kits is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for COVID-19 Kits is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of COVID-19 Kits include Assay Genie, Arista Biotech, Becton, Ellume, iHealth Lab, InBios, Quest Diagnostics, Abbott, Avellino, BioFire Diagnostics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for COVID-19 Kits, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Kits.
The COVID-19 Kits market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global COVID-19 Kits market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the COVID-19 Kits manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Assay Genie
Arista Biotech
Becton
Ellume
iHealth Lab
InBios
Quest Diagnostics
Abbott
Avellino
BioFire Diagnostics
BGI Genomics
BioMedomics
µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ
Cepheid
Chembio diagnostics
Quidel
Segment by Type
95%-99%
>99%
Segment by Application
Pharmaceutical and Biotechnology Industry
Academic and Research Centers
Diagnostic Centers
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of COVID-19 Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of COVID-19 Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 COVID-19 Kits Âé¶¹Ô´´ Overview
1.1 Product Definition
1.2 COVID-19 Kits by Type
1.2.1 Global COVID-19 Kits Âé¶¹Ô´´ Value Comparison by Type (2024 VS 2031)
1.2.2 95%-99%
1.2.3 >99%
1.3 COVID-19 Kits by Application
1.3.1 Global COVID-19 Kits Âé¶¹Ô´´ Value by Application (2024 VS 2031)
1.3.2 Pharmaceutical and Biotechnology Industry
1.3.3 Academic and Research Centers
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Global COVID-19 Kits Âé¶¹Ô´´ Size Estimates and Forecasts
1.4.1 Global COVID-19 Kits Revenue 2020-2031
1.4.2 Global COVID-19 Kits Sales 2020-2031
1.4.3 Global COVID-19 Kits Âé¶¹Ô´´ Average Price (2020-2031)
1.5 Assumptions and Limitations
2 COVID-19 Kits Âé¶¹Ô´´ Competition by Manufacturers
2.1 Global COVID-19 Kits Sales Âé¶¹Ô´´ Share by Manufacturers (2020-2025)
2.2 Global COVID-19 Kits Revenue Âé¶¹Ô´´ Share by Manufacturers (2020-2025)
2.3 Global COVID-19 Kits Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of COVID-19 Kits, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of COVID-19 Kits, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of COVID-19 Kits, Product Type & Application
2.7 Global Key Manufacturers of COVID-19 Kits, Date of Enter into This Industry
2.8 Global COVID-19 Kits Âé¶¹Ô´´ Competitive Situation and Trends
2.8.1 Global COVID-19 Kits Âé¶¹Ô´´ Concentration Rate
2.8.2 The Global 5 and 10 Largest COVID-19 Kits Players Âé¶¹Ô´´ Share by Revenue
2.8.3 Global COVID-19 Kits Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global COVID-19 Kits Âé¶¹Ô´´ Scenario by Region
3.1 Global COVID-19 Kits Âé¶¹Ô´´ Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global COVID-19 Kits Sales by Region: 2020-2031
3.2.1 Global COVID-19 Kits Sales by Region: 2020-2025
3.2.2 Global COVID-19 Kits Sales by Region: 2026-2031
3.3 Global COVID-19 Kits Revenue by Region: 2020-2031
3.3.1 Global COVID-19 Kits Revenue by Region: 2020-2025
3.3.2 Global COVID-19 Kits Revenue by Region: 2026-2031
3.4 North America COVID-19 Kits Âé¶¹Ô´´ Facts & Figures by Country
3.4.1 North America COVID-19 Kits Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America COVID-19 Kits Sales by Country (2020-2031)
3.4.3 North America COVID-19 Kits Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe COVID-19 Kits Âé¶¹Ô´´ Facts & Figures by Country
3.5.1 Europe COVID-19 Kits Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe COVID-19 Kits Sales by Country (2020-2031)
3.5.3 Europe COVID-19 Kits Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific COVID-19 Kits Âé¶¹Ô´´ Facts & Figures by Region
3.6.1 Asia Pacific COVID-19 Kits Âé¶¹Ô´´ Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific COVID-19 Kits Sales by Region (2020-2031)
3.6.3 Asia Pacific COVID-19 Kits Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America COVID-19 Kits Âé¶¹Ô´´ Facts & Figures by Country
3.7.1 Latin America COVID-19 Kits Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America COVID-19 Kits Sales by Country (2020-2031)
3.7.3 Latin America COVID-19 Kits Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa COVID-19 Kits Âé¶¹Ô´´ Facts & Figures by Country
3.8.1 Middle East and Africa COVID-19 Kits Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa COVID-19 Kits Sales by Country (2020-2031)
3.8.3 Middle East and Africa COVID-19 Kits Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global COVID-19 Kits Sales by Type (2020-2031)
4.1.1 Global COVID-19 Kits Sales by Type (2020-2025)
4.1.2 Global COVID-19 Kits Sales by Type (2026-2031)
4.1.3 Global COVID-19 Kits Sales Âé¶¹Ô´´ Share by Type (2020-2031)
4.2 Global COVID-19 Kits Revenue by Type (2020-2031)
4.2.1 Global COVID-19 Kits Revenue by Type (2020-2025)
4.2.2 Global COVID-19 Kits Revenue by Type (2026-2031)
4.2.3 Global COVID-19 Kits Revenue Âé¶¹Ô´´ Share by Type (2020-2031)
4.3 Global COVID-19 Kits Price by Type (2020-2031)
5 Segment by Application
5.1 Global COVID-19 Kits Sales by Application (2020-2031)
5.1.1 Global COVID-19 Kits Sales by Application (2020-2025)
5.1.2 Global COVID-19 Kits Sales by Application (2026-2031)
5.1.3 Global COVID-19 Kits Sales Âé¶¹Ô´´ Share by Application (2020-2031)
5.2 Global COVID-19 Kits Revenue by Application (2020-2031)
5.2.1 Global COVID-19 Kits Revenue by Application (2020-2025)
5.2.2 Global COVID-19 Kits Revenue by Application (2026-2031)
5.2.3 Global COVID-19 Kits Revenue Âé¶¹Ô´´ Share by Application (2020-2031)
5.3 Global COVID-19 Kits Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Assay Genie
6.1.1 Assay Genie Company Information
6.1.2 Assay Genie Description and Business Overview
6.1.3 Assay Genie COVID-19 Kits Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Assay Genie COVID-19 Kits Product Portfolio
6.1.5 Assay Genie Recent Developments/Updates
6.2 Arista Biotech
6.2.1 Arista Biotech Company Information
6.2.2 Arista Biotech Description and Business Overview
6.2.3 Arista Biotech COVID-19 Kits Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Arista Biotech COVID-19 Kits Product Portfolio
6.2.5 Arista Biotech Recent Developments/Updates
6.3 Becton
6.3.1 Becton Company Information
6.3.2 Becton Description and Business Overview
6.3.3 Becton COVID-19 Kits Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Becton COVID-19 Kits Product Portfolio
6.3.5 Becton Recent Developments/Updates
6.4 Ellume
6.4.1 Ellume Company Information
6.4.2 Ellume Description and Business Overview
6.4.3 Ellume COVID-19 Kits Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ellume COVID-19 Kits Product Portfolio
6.4.5 Ellume Recent Developments/Updates
6.5 iHealth Lab
6.5.1 iHealth Lab Company Information
6.5.2 iHealth Lab Description and Business Overview
6.5.3 iHealth Lab COVID-19 Kits Sales, Revenue and Gross Margin (2020-2025)
6.5.4 iHealth Lab COVID-19 Kits Product Portfolio
6.5.5 iHealth Lab Recent Developments/Updates
6.6 InBios
6.6.1 InBios Company Information
6.6.2 InBios Description and Business Overview
6.6.3 InBios COVID-19 Kits Sales, Revenue and Gross Margin (2020-2025)
6.6.4 InBios COVID-19 Kits Product Portfolio
6.6.5 InBios Recent Developments/Updates
6.7 Quest Diagnostics
6.7.1 Quest Diagnostics Company Information
6.7.2 Quest Diagnostics Description and Business Overview
6.7.3 Quest Diagnostics COVID-19 Kits Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Quest Diagnostics COVID-19 Kits Product Portfolio
6.7.5 Quest Diagnostics Recent Developments/Updates
6.8 Abbott
6.8.1 Abbott Company Information
6.8.2 Abbott Description and Business Overview
6.8.3 Abbott COVID-19 Kits Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Abbott COVID-19 Kits Product Portfolio
6.8.5 Abbott Recent Developments/Updates
6.9 Avellino
6.9.1 Avellino Company Information
6.9.2 Avellino Description and Business Overview
6.9.3 Avellino COVID-19 Kits Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Avellino COVID-19 Kits Product Portfolio
6.9.5 Avellino Recent Developments/Updates
6.10 BioFire Diagnostics
6.10.1 BioFire Diagnostics Company Information
6.10.2 BioFire Diagnostics Description and Business Overview
6.10.3 BioFire Diagnostics COVID-19 Kits Sales, Revenue and Gross Margin (2020-2025)
6.10.4 BioFire Diagnostics COVID-19 Kits Product Portfolio
6.10.5 BioFire Diagnostics Recent Developments/Updates
6.11 BGI Genomics
6.11.1 BGI Genomics Company Information
6.11.2 BGI Genomics Description and Business Overview
6.11.3 BGI Genomics COVID-19 Kits Sales, Revenue and Gross Margin (2020-2025)
6.11.4 BGI Genomics COVID-19 Kits Product Portfolio
6.11.5 BGI Genomics Recent Developments/Updates
6.12 BioMedomics
6.12.1 BioMedomics Company Information
6.12.2 BioMedomics Description and Business Overview
6.12.3 BioMedomics COVID-19 Kits Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BioMedomics COVID-19 Kits Product Portfolio
6.12.5 BioMedomics Recent Developments/Updates
6.13 µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ
6.13.1 µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ Company Information
6.13.2 µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ Description and Business Overview
6.13.3 µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ COVID-19 Kits Sales, Revenue and Gross Margin (2020-2025)
6.13.4 µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ COVID-19 Kits Product Portfolio
6.13.5 µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ Recent Developments/Updates
6.14 Cepheid
6.14.1 Cepheid Company Information
6.14.2 Cepheid Description and Business Overview
6.14.3 Cepheid COVID-19 Kits Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Cepheid COVID-19 Kits Product Portfolio
6.14.5 Cepheid Recent Developments/Updates
6.15 Chembio diagnostics
6.15.1 Chembio diagnostics Company Information
6.15.2 Chembio diagnostics Description and Business Overview
6.15.3 Chembio diagnostics COVID-19 Kits Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Chembio diagnostics COVID-19 Kits Product Portfolio
6.15.5 Chembio diagnostics Recent Developments/Updates
6.16 Quidel
6.16.1 Quidel Company Information
6.16.2 Quidel Description and Business Overview
6.16.3 Quidel COVID-19 Kits Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Quidel COVID-19 Kits Product Portfolio
6.16.5 Quidel Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 COVID-19 Kits Industry Chain Analysis
7.2 COVID-19 Kits Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 COVID-19 Kits Production Mode & Process Analysis
7.4 COVID-19 Kits Sales and Âé¶¹Ô´´ing
7.4.1 COVID-19 Kits Sales Channels
7.4.2 COVID-19 Kits Distributors
7.5 COVID-19 Kits Customer Analysis
8 COVID-19 Kits Âé¶¹Ô´´ Dynamics
8.1 COVID-19 Kits Industry Trends
8.2 COVID-19 Kits Âé¶¹Ô´´ Drivers
8.3 COVID-19 Kits Âé¶¹Ô´´ Challenges
8.4 COVID-19 Kits Âé¶¹Ô´´ Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Âé¶¹Ô´´ Size Estimation
10.1.3 Âé¶¹Ô´´ Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Assay Genie
Arista Biotech
Becton
Ellume
iHealth Lab
InBios
Quest Diagnostics
Abbott
Avellino
BioFire Diagnostics
BGI Genomics
BioMedomics
µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ
Cepheid
Chembio diagnostics
Quidel
Ìý
Ìý
*If Applicable.
